Viridian Therapeutics, Inc. (VRDN)
NASDAQ·Healthcare·Biotechnology
$29.03
+1.81%
Mkt Cap $2.87B
Analyst Ratings
Buy
18
Hold
0
Sell
0
Price Target (44 analysts)
$36.43
Range $26.00 – $43.00
Implied Upside
+25.5%
Consensus $36.43 vs current $29.03
NASDAQ·Healthcare·Biotechnology
$29.03
+1.81%
Mkt Cap $2.87B
Buy
18
Hold
0
Sell
0
Price Target (44 analysts)
$36.43
Range $26.00 – $43.00
+25.5%
Consensus $36.43 vs current $29.03